Study Summary
This trial is testing if a drug called buspirone is safe and effective for treating anxiety in kids with autism spectrum disorders. The results will be used to plan a bigger trial with more patients.
- Autism Spectrum Disorder
- Autism Spectrum Disorders
- Anxiety
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Baseline to 8 Weeks
Trial Safety
Safety Progress
Side Effects for
Trial Design
1 Treatment Group
Buspirone
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: Buspirone · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age < 18 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 24th, 2021
Last Reviewed: November 12th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Pennsylvania | 50.0% |
| Massachusetts | 25.0% |
| New York | 25.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Massachusetts General Hospital | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
| Phone Call | 100.0% |
Most responsive sites:
- Massachusetts General Hospital: < 48 hours